During the past decade, Northwell Health conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 7 clinical trials were completed, i.e. on average, 23.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwell Health" #1 sponsor was "Northwell Health" with 4 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwell Health" #1 collaborator was "Johns Hopkins University" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Cold Spring Harbor Laboratory" with 1 trials as a collaborator and "East Carolina University" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Northwell Health" are "Coronary Artery Disease" (2 trials), "Lymphoma" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Adult Solid Neoplasm" (1 trials) and "Adult-type Diffuse Gliomas" (1 trials). Many other conditions were trialed in "Northwell Health" in a lesser frequency.

Most popular intervention types in "Northwell Health" are "Drug" (19 trials), "Device" (6 trials), "Other" (5 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Placebo Oral Tablet" (2 trials), "AMG 714" (1 trials), "Anamorelin Hydrochloride" (1 trials) and "Aquacel Ag Extra" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwell Health" are 25 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northwell Health". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Northwell Health, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northwell Health, 6 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".